VABYSMO sol inj 6 mg/0.05 ml ser pré 0.175 ml

7680697090015 Pharmacode 1131140 CH-69709 S01LA09 11.99.0.

Active substances:

VABYSMO sol inj 6 mg/0.05 ml ser pré 0.175 ml
Fiches Amavita / Sun Store / Coop Vitality

Details

GTIN
7680697090015
Pharmacode
1131140
Product number
6970901
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
faricimabum 6 mg, histidinum, acidum aceticum 30 per centum ad pH, methioninum, natrii chloridum corresp. natrium 28 µg, saccharum, polysorbatum 20, aqua ad iniectabile, ad solutionem pro 0.05 ml.

Articles (1)

Vabysmo 6 mg/0.05 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
faricimabum
6.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
acidum aceticum 30 per centum
- Substance HNIDK
methioninum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrium
28.0 UG Substance HBESI
saccharum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 882.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2025

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
69709
Drug name
Vabysmo, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
S01LA09
Authorization status
Z
Dispensation category
B
First authorization
04/12/2024
Authorization expiration date
03/12/2029
IT number
11.99.0.
Domain
Human medicine
Field of application
Neovaskuläre altersbedingte Makuladegeneration und diabetisches Makulaödem, Behandlung eines Makulaödems infolge eines retinalen Venenverschlusses (BRVO und CRVO)

Packaging details

Description (FR)
VABYSMO sol inj 6 mg/0.05 ml ser pré 0.175 ml
Description (DE)
VABYSMO Inj Lös 6 mg/0.05 ml Fertspr 0.175 ml
Market launch
04/12/2024
Narcotic (BTM)
No
Buy us a coffee Explore the data